Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses

Luděk Eyer; Darina Zouharová; Jana Širmarová; Martina Fojtíková; Michal Štefánik; Jan Haviernik; Radim Nencka; De Clercq Erik; Daniel Růžek

doi:10.1016/j.antiviral.2017.03.012

Article2015

Nucleoside Inhibitors of Tick-Borne Encephalitis Virus

Luděk Eyer, James J. Valdés, V. Gil, Radim Nencka, Hubert Hřebabecký, Michal Šála, Jiřı́ Salát, Jiří Černý, Martin Palus, De Clercq Erik, Daniel Růžek

Article2019

An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice

Luděk Eyer, Antoine Nougaırède, Marie Uhlířová, Jean‐Sélim Driouich, Darina Zouharová, James J. Valdés, Jan Haviernik, Ernest A. Gould, De Clercq Erik, Xavier de Lamballerie, Daniel Růžek

Article2020

An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus in Mice

Jan Haviernik, Luděk Eyer, Antoine Nougaırède, Marie Uhlířová, Jean‐Sélim Driouich, Darina Zouharová, James J. Valdés, Ernest Gould, De Clercq Erik, Xavier de Lamballerie, Daniel Růžek

Preprint2019

An E460D substitution in the NS5 protein of tick-borne encephalitis virus confers resistance to the inhibitor Galidesivir (BCX4430) and also attenuates the virus for mice

Luděk Eyer, Antoine Nougaırède, Marie Uhlířová, Jean‐Sélim Driouich, Darina Zouharová, James J. Valdés, Jan Haviernik, Ernest A. Gould, De Clercq Erik, Xavier de Lamballerie, Daniel Růžek

Article2018

Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses

Luděk Eyer, Radim Nencka, De Clercq Erik, Katherine L. Seley‐Radtke, Daniel Růžek

Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses

Discussion(0)

Related publications

Nucleoside Inhibitors of Tick-Borne Encephalitis Virus

An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice

An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus in Mice

An E460D substitution in the NS5 protein of tick-borne encephalitis virus confers resistance to the inhibitor Galidesivir (BCX4430) and also attenuates the virus for mice

Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses